Design, Synthesis, and Biological Evaluation of Tetrahydropyridine Analogues as Potent Antibiofilm Agents against <i>S. aureus</i> : In Vitro and In Silico Studies

An ecofriendly approach has been developed for the highly efficient atom-economical one-pot multicomponent synthesis of substituted tetrahydropyridine scaffolds as potent antibiofilm agents via using 1,2,4,5-Benzenetetracarboxylic acid (H<sub>4</sub>BTCA) as a novel, mild organocatalyst. This is the first-ever report on the use of 1,2,4,5-Benzenetetracarboxylic acid (H<sub>4</sub>BTCA) as a catalyst in organic synthesis. This protocol's appealing features include column chromatography-free purification, resulting in high-purity products and compatibility with a broad range of substrates. Moreover, this method afforded good results to excellent yields (i.e., 86-93%) of compounds (<b>4a</b>-<b>4r</b>). The biological utility of the tetrahydropyridine derivatives as antibiofilm agents has been demonstrated. The synthesized compounds were screened against <i>Staphylococcus aureus</i> and <i>P. aeruginosa</i> with in vitro and in silico approaches. It is noteworthy to mention that some of the tetrahydropyridine derivatives exhibited potent antibiofilm activity with minimum or no toxicity in the in vitro study. On the basis of antibiofilm activity, 3 compounds (<b>4k</b>, <b>4l</b>, and <b>4n</b>) were formulated into nanoparticles (<b>4k</b> NPs, 4l NPs, <b>4n</b> NPs) have shown appreciable antibiofilm activity with a maximum disruption, 87.74 ± 2.26%, shown by 4l NPs and toxicity further reduced below 2% when the compound was loaded into nanoparticles. The docking studies of the active 3 compounds (<b>4k</b>, <b>4l</b>, and <b>4n</b>) have been tested against different biofilm target proteins like sarA, crtM, fnbA, PBP2, clfA, clfB, AgrA, and AgrC associated with the <i>S. aureus</i> biofilm. Our in silico study results demonstrate the high affinity of the molecules with lower (more negative) docking scores ranging from ∼-10 to -6 kcal/mol. The highest affinities were observed with <b>4k</b> and <b>4b</b> against the 1n67 protein (clumping factor protein) compared to other studied antibiofilm-related proteins.

Authors

Institutions

Publication Details

Journal
ACS Omega
Published
2025-12-31
DOI
https://doi.org/10.1021/acsomega.5c05577
Primary Topic
Multicomponent Synthesis of Heterocycles
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Design, Synthesis, and Biological Evaluation of Tetrahydropyridine Analogues as Potent Antibiofilm Agents against S. aureus : In Vitro and In Silico Studies

Awadh Bihari Yadav, Reema Singh, Pramod Katara, Sarita Maurya et al.
ACS Omega
Multicomponent Synthesis of Heterocycles
article

Design, Synthesis, and Biological Evaluation of Tetrahydropyridine Analogues as Potent Antibiofilm Agents against S. aureus : In Vitro and In Silico Studies

Awadh Bihari Yadav, Reema Singh, Pramod Katara, Sarita Maurya, Gyanendra Chaudhary, Aman Verma, Bappa Manna, Shivani Tyagi, Deepti Verma, Amit Prabhakar
article en

Abstract

An ecofriendly approach has been developed for the highly efficient atom-economical one-pot multicomponent synthesis of substituted tetrahydropyridine scaffolds as potent antibiofilm agents via using 1,2,4,5-Benzenetetracarboxylic acid (H<sub>4</sub>BTCA) as a novel, mild organocatalyst. This is the first-ever report on the use of 1,2,4,5-Benzenetetracarboxylic acid (H<sub>4</sub>BTCA) as a catalyst in organic synthesis. This protocol's appealing features include column chromatography-free purification, resulting in high-purity products and compatibility with a broad range of substrates. Moreover, this method afforded good results to excellent yields (i.e., 86-93%) of compounds (<b>4a</b>-<b>4r</b>). The biological utility of the tetrahydropyridine derivatives as antibiofilm agents has been demonstrated. The synthesized compounds were screened against <i>Staphylococcus aureus</i> and <i>P. aeruginosa</i> with in vitro and in silico approaches. It is noteworthy to mention that some of the tetrahydropyridine derivatives exhibited potent antibiofilm activity with minimum or no toxicity in the in vitro study. On the basis of antibiofilm activity, 3 compounds (<b>4k</b>, <b>4l</b>, and <b>4n</b>) were formulated into nanoparticles (<b>4k</b> NPs, 4l NPs, <b>4n</b> NPs) have shown appreciable antibiofilm activity with a maximum disruption, 87.74 ± 2.26%, shown by 4l NPs and toxicity further reduced below 2% when the compound was loaded into nanoparticles. The docking studies of the active 3 compounds (<b>4k</b>, <b>4l</b>, and <b>4n</b>) have been tested against different biofilm target proteins like sarA, crtM, fnbA, PBP2, clfA, clfB, AgrA, and AgrC associated with the <i>S. aureus</i> biofilm. Our in silico study results demonstrate the high affinity of the molecules with lower (more negative) docking scores ranging from ∼-10 to -6 kcal/mol. The highest affinities were observed with <b>4k</b> and <b>4b</b> against the 1n67 protein (clumping factor protein) compared to other studied antibiofilm-related proteins.

ACS OmegaVol. 11(1)
University of Allahabad (IN), Indian Institute of Information Technology Allahabad (IN), Department of Biotechnology (IN), Bioinformatics Institute (SG), Institute of Bioinformatics (IN)
Openalex Percentile: Top 32%
Multicomponent Synthesis of Heterocycles
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.